Assert India

Resverlogix Scientific Data Presented at EAS Congress
New data from Phase 1b/2a trial included TSX Exchange Symbol: RVX HAMBURG, Germany and CALGARY, AB, June 22 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that key scientific data was communicated in an oral presentation highlighting the novel features of the Company's lead drug RVX-208 at the European Atherosclerosis Society Congress (EAS) conference being held in Hamburg, Germany.

Communique of The G(irls)20 Summit
Toronto, Canada June 15 - 18, 2010 OTTAWA, June 18 /PRNewswire/ - Preamble We, the 21 delegates of the first ever G(irls)20 Summit, know that girls and women have the potential to play a pivotal role in building communities and countries and being catalysts for economic progress around the globe. We come together in the days before the gathering of the leaders of the world's most powerful nations at the G-8 and G-20 meetings to be the voice that reminds the leaders of the importance of eliminating barriers for girls and women everywhere, and to mobilize change-makers worldwide to add their voices to ours. We are here because: We know that education opens doors for girls and women, yet nearly 4...

Resverlogix Completes Dosing for ASSERT Trial
Completion occurs 5 months ahead of schedule TSX Exchange Symbol: RVX CALGARY, May 12 /PRNewswire-FirstCall/ - Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing.

Anyone Can Prove and Assert Ownership of Their Online Identity With New PeoplePond Service
This is the first time personal identity verification and social media, blog and online content ownership authentication have been offered together. The combination provides a new opportunity to authentic a person's entire online identity (http://www.peoplepond.com), sparing their followers from falling prey to impersonators and while providing a trusted platform from which to promote online content.

PeoplePond Enables Bloggers to Assert Ownership Over Their Online Identity
PeoplePond is now enabling bloggers to use the PeoplePond Personal Identity Verification (http://www.peoplepond.com) service and Online Identity Verification to defend against identity spoofing and provide their audiences with trusted online content.


	Assert India

	Home - Site Map - This Site Is For Sale Resverlogix Scientific Data Presented at EAS Congress New data from Phase 1b/2a trial included TSX Exchange Symbol: RVX HAMBURG, Germany and CALGARY, AB, June 22 /PRNewswire-FirstCall/ - Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that key scientific data was communicated in an oral presentation highlighting the novel features of the Company's lead drug RVX-208 at the European Atherosclerosis Society Congress (EAS) conference being held in Hamburg, Germany. Communique of The G(irls)20 Summit Toronto, Canada June 15 - 18, 2010 OTTAWA, June 18 /PRNewswire/ - Preamble We, the 21 delegates of the first ever G(irls)20 Summit, know that girls and women have the potential to play a pivotal role in building communities and countries and being catalysts for economic progress around the globe. We come together in the days before the gathering of the leaders of the world's most powerful nations at the G-8 and G-20 meetings to be the voice that reminds the leaders of the importance of eliminating barriers for girls and women everywhere, and to mobilize change-makers worldwide to add their voices to ours. We are here because: We know that education opens doors for girls and women, yet nearly 4... Resverlogix Completes Dosing for ASSERT Trial Completion occurs 5 months ahead of schedule TSX Exchange Symbol: RVX CALGARY, May 12 /PRNewswire-FirstCall/ - Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. Anyone Can Prove and Assert Ownership of Their Online Identity With New PeoplePond Service This is the first time personal identity verification and social media, blog and online content ownership authentication have been offered together. The combination provides a new opportunity to authentic a person's entire online identity (http://www.peoplepond.com), sparing their followers from falling prey to impersonators and while providing a trusted platform from which to promote online content. PeoplePond Enables Bloggers to Assert Ownership Over Their Online Identity PeoplePond is now enabling bloggers to use the PeoplePond Personal Identity Verification (http://www.peoplepond.com) service and Online Identity Verification to defend against identity spoofing and provide their audiences with trusted online content.		Assertion in Java Assertion facility is added in J2SE 1.4. PeoplePond Profile Owners Can Now Assert Ownership Over Their Online Identity PeoplePond's new social media authentication (http://www.peoplepond.com) Internet service enables people to claim ownership of their social media accounts providing followers with assurance they aren't being spoofed by someone else. Violating Boundaries: Assert Yourself and Take Charge "They that can give up essential liberty to obtain a little temporary safety deserve neither liberty nor safety." – Benjamin FranklinAre you sick and tired of being treated like a doormat and having people walk all over you? If you answered yes, read on. Dealing With Labor Law Violation In the United States, there are many laws that protect employees. Labor law violations are considered a serious matter and are punishable by law. Employees must know what their rights are and how to assert them in the workplace. This helps them know when their employees are making labor law violations and what steps they should take to defend themselves. EM&I Launches ACART to Help Government Agencies Address Enterprise Architecture and Requirements Compliance New Offering Helps Agencies Compare Systems against Architectures, Requirements and Regulations and Then Document and Report on Compliance Status Resverlogix Completes Dosing for ASSERT Trial Completion occurs 5 months ahead of schedule TSX Exchange Symbol: RVX CALGARY, May 12 /PRNewswire-FirstCall/ - Resverlogix is pleased to announce that the Phase 2 ASSERT clinical trial for its lead drug, RVX-208, a small molecule therapy for the treatment of atherosclerosis has now completed dosing. Using India Exporters For Business Even though many people may not be aware of the many product industries that India gets involved with as far as the buying and selling of goods is concerned, there is more to India than meets the eye There are actually a plethora of exporters located within India and the surrounding areas Boost Your Assertiveness: A Walk Through 32 Techniques Undoubtedly, there are instances wherein all of us wish we could better assert ourselves and assert things without fear, inhibition or hesitation. Have you ever looked at yourself in the mirror and squirmed at the image of someone who had failed to assert himself? Sometimes there are instances when it feels as if we are unable to overcome our inability to say or do the right things.